Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | -2.05% | +1.70% | -52.20% |
03-15 | AC Immune Files $350 Million Mixed Shelf | MT |
03-14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 147
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic and Diagnostic Products
100.0
%
| 4 | 100.0 % | 16 | 100.0 % | +299.75% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 4 | 100.0 % | 16 | 100.0 % | +299.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrea Pfeifer
FOU | Founder | 66 | 03-02-12 |
Director of Finance/CFO | 35 | 18-12-31 | |
Nuno Mendonça
CTO | Chief Tech/Sci/R&D Officer | 42 | 23-09-30 |
Oliver Sol
CTO | Chief Tech/Sci/R&D Officer | 58 | 15-12-31 |
Madiha Derouazi
CTO | Chief Tech/Sci/R&D Officer | 51 | 12-31 |
Chief Tech/Sci/R&D Officer | 54 | 18-05-31 | |
Chief Administrative Officer | 54 | 09-02-28 | |
Gary Waanders
IRC | Investor Relations Contact | 60 | - |
Howard Donovan
HRO | Human Resources Officer | 49 | 22-04-17 |
Julian Snow
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Williams
CHM | Chairman | 66 | 17-12-31 |
Carl June
BRD | Director/Board Member | 70 | 20-11-19 |
Werner Lanthaler
BRD | Director/Board Member | 56 | 18-07-05 |
Andrea Pfeifer
FOU | Founder | 66 | 03-02-12 |
Monika Bütler
BRD | Director/Board Member | 63 | 21-10-28 |
Roy Ervin Twyman
BRD | Director/Board Member | 68 | 18-12-31 |
Monica Shaw
BRD | Director/Board Member | 46 | 21-10-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 104,441,787 | 57,662,113 ( 55.21 %) | 5,243,958 ( 5.021 %) | 55.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.20% | 229M | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- ACIU Stock
- Company AC Immune SA